Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.7K Sell
1,053
-274
-21% -$12.8K 0.02% 207
2025
Q4
$64.3K Sell
1,327
-211
-14% -$10.5K 0.03% 193
2025
Q3
$72.6K Buy
1,538
+273
+22% +$13.2K 0.03% 152
2025
Q2
$61.1K Sell
1,265
-123
-9% -$6.29K 0.03% 160
2025
Q1
$77K Buy
1,388
+108
+8% +$5.85K 0.05% 119
2024
Q4
$61.7K Buy
1,280
+173
+16% +$8.8K 0.04% 141
2024
Q3
$63.8K Hold
1,107
0.04% 141
2024
Q2
$53.7K Sell
1,107
-191
-15% -$9.21K 0.04% 145
2024
Q1
$63.1K Buy
1,298
+604
+87% +$29.5K 0.05% 133
2023
Q4
$34.5K Buy
+694
New +$33.9K 0.03% 174

Other funds holding SNY

WealthCollab's SNY Position: Q1 2026 in Review

WealthCollab reduced its Sanofi (SNY) stake by 21% in Q1 2026, selling an estimated $12.8K and leaving 1,053 shares worth $50.7K. The position accounts for 0.02% of the portfolio, ranked #207.

WealthCollab first reported a position in SNY in Q4 2023 and has held it in 10 quarters since. The position peaked at $77K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • WealthCollab held 1,053 shares of Sanofi worth $50.7K as of Q1 2026.
  • WealthCollab sold 274 Sanofi shares in Q1 2026, an estimated $12.8K.
  • Sanofi made up 0.02% of WealthCollab's portfolio in Q1 2026, its #207 holding.
  • WealthCollab first reported a position in Sanofi in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Sanofi position peaked at $77K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.